Related Experiment Video

Updated: Aug 24, 2026

Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice
09:50

Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice

Published on: February 11, 2019

Chronic graft-versus-host disease: clinical features and grading systems

Gérard Socié1

  • 1Service d'Hématologie/Greffe de Moelle, Hôpital Saint Louis, 1 Avenue Claude Vellefaux, 75475, Paris, France. gsocie@chu-stlouis.fr

International Journal of Hematology
|June 1, 2004
PubMed

Insights

Chronic graft-versus-host disease (GVHD) is a major cause of death after marrow transplants. Current methods for assessing GVHD severity lack clear superiority, necessitating further validation of grading scales.

Area of Science:

  • Hematology
  • Immunology
  • Transplantation Medicine

Background:

  • Chronic graft-versus-host disease (GVHD) is the primary cause of late mortality post-marrow transplantation.
  • It is also a significant contributor to non-malignant complications following transplantation.
  • Effective management of chronic GVHD is hindered by challenges in accurately assessing disease severity.

Purpose of the Study:

  • To summarize the clinical symptoms and diagnostic challenges of chronic GVHD.
  • To critically review existing grading systems for chronic GVHD severity.
  • To evaluate the need for prospective validation of the Johns Hopkins grading scale.

Main Methods:

  • Literature review of clinical symptoms and diagnostic issues in chronic GVHD.
  • Critical analysis of published grading systems for chronic GVHD severity.
  • Assessment of the current evidence regarding the efficacy of different grading scales.

Main Results:

  • Existing grading systems for chronic GVHD severity have not demonstrated a clear advantage over one another.
  • A significant unmet need exists for a validated, reliable method to assess chronic GVHD severity.
  • The current landscape of chronic GVHD assessment lacks a universally accepted superior grading system.

Conclusions:

  • Accurate assessment of chronic GVHD severity remains a critical challenge in transplantation medicine.
  • Further prospective validation of established grading scales, such as the Johns Hopkins scale, is essential.
  • Standardizing GVHD assessment is crucial for improving patient outcomes and guiding treatment decisions.

More Related Videos

Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR06:06

Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR

Published on: May 23, 2019

Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model10:29

Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model

Published on: August 29, 2012

Related Concept Videos

Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...